After signing a drug pricing deal with the White House, J&J will now offer some of its branded medicines at discounted rates ...

As we enter January 2026, the Asian markets are capturing attention with a mix of optimism and caution, particularly as China's manufacturing sector shows signs of recovery and South Korea's ...

The American drugmaker was one of 17 companies US President Donald Trump called on last summer to lower prices, and among the ...

Detailed price information for Bristol-Myers Squibb Company (BMY-N) from The Globe and Mail including charting and trades.

No matter where you are in your investment journey, dividends can become the backbone of your income. Dividend stocks are an ideal way to generate money from your investment; they can help cover ...

Alveus Therapeutics is a clinical-stage biotechnology company developing next-generation therapies for obesity and metabolic diseases, designed for sustained efficacy, improved tolerability, and ...

Fintel reports that on January 7, 2026, UBS upgraded their outlook for Bristol-Myers Squibb Company - Preferred Security (OTCPK:BMYMP) from Neutral to Buy. Analyst Price Forecast Suggests 25.45% ...

As per DelveInsight estimates, the total prevalent population of prostate cancer in the 7MM was nearly 8,241,000 cases in 2023. These cases are projected to increase during the forecast period, i.e., ...

Join Bristol Myers Squibb, Genentech, Google, J.P. Morgan, Novo Nordisk, Pappas Capital, Amazon Web Services, BIO, Members of ...

Elephas Biosciences Corporation (Elephas), a private company that has developed an innovative live tissue platform for immunotherapy response prediction, announced today the expansion of its ...

The Dow" is short for the Dow Jones Industrial Average. It's often used as a proxy for the entire U.S. stock market.

Just in time for the holidays, on December 15, 2025, the U.S. Food and Drug Administration (“FDA”) Office of Prescription Drug Promotion (“OPDP”) issued an untitled letter (the “Letter”) to Karuna ...